Brief: Immutep Secures Third U.S. Patent For Eftilagimod Alpha With Pd-1 Pathway Inhibitor

Immutep

27/06/2023 07:13

June 27 (Reuters) - Immutep Ltd  IMM.AX :
    * SECURES THIRD UNITED STATES PATENT FOR EFTILAGIMOD ALPHA
WITH A
PD-1 PATHWAY INHIBITOR

Source text for Eikon:  ID:nASX1SclP6 
Further company coverage:  IMM.AX 

 ((Reuters.Briefs@thomsonreuters.com;))